Advancements in Alzheimer's Disease Therapy: The Role of Anti-Amyloid Monoclonal Antibodies - A Literature Review

Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline and neuronal damage. Anti-amyloid monoclonal antibodies such as aducanumab, lecanemab, and donanemab, represent the first disease-modifying therapies for Alzheimer’s disease, specifically targeting am...

Description complète

Détails bibliographiques

Auteurs principaux:	Agnieszka Skoczeń, Natalia Rutecka, Błażej Kaczmarek, Agata Kuśnierz-Gibała, Adrian Kruk, Michał Kulesza, Weronika Wawrzynów, Martyna Miłoś, Aleksandra Dorosz, Magdalena Maria Jakubowska
Format:	Artigo
Langue:	Inglês
Publié:	Kazimierz Wielki University 2025-03-01
Collection:	Journal of Education, Health and Sport
Sujets:	Alzheimer's disease anti-amyloid monoclonal antibodies aducanumab lecanemab donanemab ARIA
Accès en ligne:	https://apcz.umk.pl/JEHS/article/view/58362
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!